Carbapenem Resistance in Gram-Negative Bacteria: The Not-So-Little Problem in the Little Red Dot

Jocelyn Qi Min Teo, Yiying Cai, Tze-Peng Lim, Thuan Tong Tan, Andrea Lay-Hoon Kwa, Jocelyn Qi Min Teo, Yiying Cai, Tze-Peng Lim, Thuan Tong Tan, Andrea Lay-Hoon Kwa

Abstract

Singapore is an international travel and medical hub and faces a genuine threat for import and dissemination of bacteria with broad-spectrum resistance. In this review, we described the current landscape and management of carbapenem resistance in Gram-negative bacteria (GNB) in Singapore. Notably, the number of carbapenem-resistant Enterobacteriaceae has exponentially increased in the past two years. Resistance is largely mediated by a variety of mechanisms. Polymyxin resistance has also emerged. Interestingly, two Escherichia coli isolates with plasmid-mediated mcr-1 genes have been detected. Evidently, surveillance and infection control becomes critical in the local setting where resistance is commonly related to plasmid-mediated mechanisms, such as carbapenemases. Combination antibiotic therapy has been proposed as a last-resort strategy in the treatment of extensively drug-resistant (XDR) GNB infections, and is widely adopted in Singapore. The diversity of carbapenemases encountered, however, presents complexities in both carbapenemase detection and the selection of optimal antibiotic combinations. One unique strategy introduced in Singapore is a prospective in vitro combination testing service, which aids physicians in the selection of individualized combinations. The outcome of this treatment strategy has been promising. Unlike countries with a predominant carbapenemase type, Singapore has to adopt management strategies which accounts for diversity in resistance mechanisms.

Keywords: antibiotic combinations; carbapenemase; extensively-drug resistant; infection control; molecular epidemiology.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
(a) Number of non-duplicate key Gram-negative pathogens in Singapore General Hospital from 2011 to 2015; * includes data from the first 10 months; and (b) Carbapenem non-susceptibility rates (% intermediate and resistant) of non-duplicate key Gram-negative pathogens in Singapore General Hospital from 2011 to 2015; * includes data from the first 10 months.

References

    1. Paterson D.L., Doi Y. A step closer to extreme drug resistance (XDR) in Gram-negative bacilli. Clin. Infect. Dis. Off. Pub. Infect. Dis. Soc. Am. 2007;45:1179–1181. doi: 10.1086/522287.
    1. Jean S.S., Hsueh P.R. High burden of antimicrobial resistance in Asia. Int. J. Antimicrob. Agents. 2011;37:291–295. doi: 10.1016/j.ijantimicag.2011.01.009.
    1. Hawkey P.M. Multidrug-resistant Gram-negative bacteria: A product of globalization. J. Hosp. Infect. 2015;89:241–247. doi: 10.1016/j.jhin.2015.01.008.
    1. World Health Organization Antimicrobial Resistance: Global Report on Surveillance. [(accessed on 30 November 2015)]. Available online: .
    1. Molton J.S., Tambyah P.A., Ang B.S., Ling M.L., Fisher D.A. The global spread of healthcare-associated multidrug-resistant bacteria: A perspective from Asia. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2013;56:1310–1318.
    1. Hsu L.Y., Tan T.Y., Tam V.H., Kwa A., Fisher D.A., Koh T.H. Network for Antimicrobial Resistance Surveillance (Singapore). Surveillance and correlation of antibiotic prescription and resistance of Gram-negative bacteria in Singaporean hospitals. Antimicrob. Agents Chemother. 2010;54:1173–1178. doi: 10.1128/AAC.01076-09.
    1. Tan T.Y., Hsu L.Y., Koh T.H., Ng L.S., Tee N.W., Krishnan P., Lin R.T., Jureen R. Antibiotic resistance in Gram-negative bacilli: A Singapore perspective. Ann. Acad Med. Singap. 2008;37:819–825.
    1. Koh T.H., Cao D., Shan Q.Y., Bacon A., Hsu L.Y., Ooi E.E. Acquired carbapenemases in enterobactericeae in Singapore, 1996–2012. Pathology. 2013;45:600–603. doi: 10.1097/PAT.0b013e3283650b1e.
    1. Teo J., Lim T.P., Cai Y., Koh T.H., Tan T.T., Koh T.H., Kwa A.L. Molecular epidemiology of carbapenem-resistant Gram negative bacteria in Singapore. Antimicrob. Agents Chemother. 2016 submitted.
    1. Krishnan P.U., La M.V., Jureen R., Koh M., Teo J., Lin R. Changing trends in carbapenemase-producing Enterobacteriaceae in Singapore from 2010 to 2014 (August); Proceedings of the 25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark. 25–28 April 2015.
    1. Koh T.H., Ko K., Jureen R., Deepak R.N., Tee N.W., Tan T.Y., Tay M.R., Lee V.J., Barkham T.M. High counts of carbapenemase-producing Enterobacteriaceae in hospital sewage. Infect. Control. Hosp. Epidemiol. 2015;36:619–621. doi: 10.1017/ice.2015.44.
    1. Teo J., Lee S., Leck H., Chia S., Wang R., Cai Y., Lim T.P., Koh T.H., Tan T.T., Kwa A.L. Molecular characterization of carbapenem-resistant Klebsiella species in Singapore; Proceedings of the 25th European Congress of Clinical Microbiology and Infectious Diseases; Copenhagen, Denmark. 25–28 April 2015.
    1. Alekshun M.N., Levy S.B. Molecular mechanisms of antibacterial multidrug resistance. Cell. 2007;128:1037–1050. doi: 10.1016/j.cell.2007.03.004.
    1. Nordmann P., Poirel L. The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2014;20:821–830. doi: 10.1111/1469-0691.12719.
    1. Nordmann P., Naas T., Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 2011;17:1791–1798. doi: 10.3201/eid1710.110655.
    1. Balm M.N., Ngan G., Jureen R., Lin R.T., Teo J.W. Oxa-181-producing Klebsiella pneumoniae establishing in Singapore. BMC Infect. Dis. 2013 doi: 10.1186/1471-2334-13-58.
    1. Koh T.H., Babini G.S., Woodford N., Sng L.H., Hall L.M., Livermore D.M. Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore. Lancet. 1999 doi: 10.1016/S0140-6736(05)75604-X.
    1. Koh T.H., Khoo C.T., Wijaya L., Leong H.N., Lo Y.L., Lim L.C., Koh T.Y. Global spread of New Delhi metallo-beta-lactamase 1. Lancet Infect. Dis. 2010 doi: 10.1016/S1473-3099(10)70274-7.
    1. Balm M.N., Ngan G., Jureen R., Lin R.T., Teo J. Molecular characterization of newly emerged blaKPC-2-producing Klebsiella pneumoniae in Singapore. J. Clin. Microbiol. 2012;50:475–476. doi: 10.1128/JCM.05914-11.
    1. Marimuthu K., Teo J.W., Fong P.B., Chin J.O., Qi K.J., Boon D.L., Ping A.C., Krishnan P., Peng B.A. First report of emergence of OXA-48 carbapenemase-producing Enterobacteriaceae in Singapore: Proactive or reactive infection control strategy? Am. J. Infect. Control. 2014;42:577–578. doi: 10.1016/j.ajic.2014.01.021.
    1. Teo J.W., La M.V., Krishnan P., Ang B., Jureen R., Lin R.T. Enterobacter cloacae producing an uncommon class a carbapenemase, IMI-1, from Singapore. J. Med. Microbiol. 2013;62:1086–1088. doi: 10.1099/jmm.0.053363-0.
    1. Teo J.W., Kurup A., Lin R.T., Hsien K.T. Emergence of clinical Klebsiella pneumoniae producing OXA-232 carbapenemase in Singapore. New Microbes New Infect. 2013;1:13–15. doi: 10.1002/2052-2975.4.
    1. Balm M.N., La M.V., Krishnan P., Jureen R., Lin R.T., Teo J.W. Emergence of Klebsiella pneumoniae co-producing NDM-type and OXA-181 carbapenemases. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2013;19:E421–E423. doi: 10.1111/1469-0691.12247.
    1. Koh T.H., Sng L.H., Wang G.C., Hsu L.Y., Zhao Y. IMP-4 and oxa beta-lactamases in Acinetobacter baumannii from Singapore. J. Antimicrob. Chemother. 2007;59:627–632. doi: 10.1093/jac/dkl544.
    1. Koh T.H., Sng L.H., Wang G.C., Hsu L.Y., Zhao Y. Carbapenemase and efflux pump genes in acinetobacter calcoaceticus Acinetobacter baumannii complex strains from Singapore. J. Antimicrob. Chemother. 2007;60:1173–1174. doi: 10.1093/jac/dkm334.
    1. Koh T.H., Wang G.C., Sng L.H. Clonal spread of IMP-1-producing Pseudomonas aeruginosa in two hospitals in Singapore. J. Clin. Microbiol. 2004;42:5378–5380. doi: 10.1128/JCM.42.11.5378-5380.2004.
    1. Koh T.H., Khoo C.T., Tan T.T., Arshad M.A., Ang L.P., Lau L.J., Hsu L.Y., Ooi E.E. Multilocus sequence types of carbapenem-resistant Pseudomonas aeruginosa in Singapore carrying metallo-beta-lactamase genes, including the novel blaIMP-26 gene. J. Clin. Microbiol. 2010;48:2563–2564. doi: 10.1128/JCM.01905-09.
    1. Koh T.H., Wang G.C., Sng L.H. IMP-1 and a novel metallo-beta-lactamase, VIM-6, in fluorescent pseudomonads isolated in Singapore. Antimicrob. Agents Chemother. 2004;48:2334–2336. doi: 10.1128/AAC.48.6.2334-2336.2004.
    1. Koh T.H. Ph.D. Thesis. National University of Singapore; Singapore: 2013. Acquired Carbapenemases in Gram-Negative Bacilli in Singapore.
    1. Park Y.K., Lee G.H., Baek J.Y., Chung D.R., Peck K.R., Song J.H., Ko K.S. A single clone of Acinetobacter baumannii, ST22, is responsible for high antimicrobial resistance rates of Acinetobacter spp. Isolates that cause bacteremia and urinary tract infections in Korea. Microb. Drug Resist. 2010;16:143–149. doi: 10.1089/mdr.2009.0088.
    1. Samuelsen O., Toleman M.A., Sundsfjord A., Rydberg J., Leegaard T.M., Walder M., Lia A., Ranheim T.E., Rajendra Y., Hermansen N.O., et al. Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from norway and Sweden shows import of international clones and local clonal expansion. Antimicrob. Agents Chemother. 2010;54:346–352. doi: 10.1128/AAC.00824-09.
    1. Teo J., Ngan G., Balm M., Jureen R., Krishnan P., Lin R. Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals. West. Pac. Surveill. Response J. 2012;3:19–24. doi: 10.5365/wpsar.2011.2.4.010.
    1. Abate G., Koh T.H., Gardner M., Siu L.K. Clinical and bacteriological characteristics of Klebsiella pneumoniae causing liver abscess with less frequently observed multi-locus sequences type, ST163, from Singapore and Missouri, US. J. Microbiol. Immunol. Infect. 2012;45:31–36. doi: 10.1016/j.jmii.2011.09.002.
    1. Liu Y.Y., Wang Y., Walsh T.R., Yi L.X., Zhang R., Spencer J., Doi Y., Tian G., Dong B., Huang X., et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: A microbiological and molecular biological study. Lancet Infect. Dis. 2015 doi: 10.1016/S1473-3099(15)00424-7.
    1. Lim T.P., Ong R.T., Hon P.Y., Hawkey J., Holt K.E., Koh T.H., Leong M.L., Teo J.Q., Tan T.Y., Ng M.M., et al. Multiple genetic mutations associated with polymyxin resistance in Acinetobacter baumannii. Antimicrob. Agents Chemother. 2015;59:7899–7902. doi: 10.1128/AAC.01884-15.
    1. Teo J., Ong Rick T., Koh T.H., Lim T.P., Kwa A.L. Multidrug-resistant Escherichia coli co-harbouring blaKPC-2 and MCR-1 in Singapore. Lancet. 2016 under review.
    1. Ministry of Health Guidelines for Control and Prevention of Multi-Drug Resistant Organisms (MDROs) in Healthcare Facilities. [(accessed on 30 November 2015)]; Available online: .
    1. Nordmann P., Poirel L. Strategies for identification of carbapenemase-producing Enterobacteriaceae. J. Antimicrob. Chemother. 2013;68:487–489. doi: 10.1093/jac/dks426.
    1. Hammoudi D., Moubareck C.A., Sarkis D.K. How to detect carbapenemase producers? A literature review of phenotypic and molecular methods. J. Microbiol. Methods. 2014;107:106–118. doi: 10.1016/j.mimet.2014.09.009.
    1. Nordmann P., Gniadkowski M., Giske C.G., Poirel L., Woodford N., Miriagou V., European Network on Carbapenemases Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2012;18:432–438.
    1. Hrabak J., Chudackova E., Papagiannitsis C.C. Detection of carbapenemases in Enterobacteriaceae: A challenge for diagnostic microbiological laboratories. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2014;20:839–853. doi: 10.1111/1469-0691.12678.
    1. Nordmann P., Poirel L., Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 2012;18:1503–1507. doi: 10.3201/eid1809.120355.
    1. Tijet N., Boyd D., Patel S.N., Mulvey M.R., Melano R.G. Evaluation of the carba np test for rapid detection of carbapenemase-producing Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 2013;57:4578–4580. doi: 10.1128/AAC.00878-13.
    1. Clinical and Laboratory Standards Institute . Performance Standards for Antimicrobial Testing: Seventeenth Informational Supplement M100-S20. Volume 30 Clinical and Laboratory Standards Institute; Wayne, PA, USA: 2010.
    1. Girlich D., Poirel L., Nordmann P. Value of the modified hodge test for detection of emerging carbapenemases in Enterobacteriaceae. J. Clin. Microbiol. 2012;50:477–479. doi: 10.1128/JCM.05247-11.
    1. Miriagou V., Cornaglia G., Edelstein M., Galani I., Giske C.G., Gniadkowski M., Malamou-Lada E., Martinez-Martinez L., Navarro F., Nordmann P., et al. Acquired carbapenemases in gram-negative bacterial pathogens: Detection and surveillance issues. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2010;16:112–122. doi: 10.1111/j.1469-0691.2009.03116.x.
    1. Pasteran F., Mendez T., Guerriero L., Rapoport M., Corso A. Sensitive screening tests for suspected class a carbapenemase production in species of Enterobacteriaceae. J. Clin. Microbiol. 2009;47:1631–1639. doi: 10.1128/JCM.00130-09.
    1. Teo J., Kwa A.L., Loh J., Chlebicki M.P., Lee W. The effect of a whole-system approach in an antimicrobial stewardship programme at the Singapore general hospital. Eur. J. Clin. Microbiol. Infect. Dis. 2012;31:947–955. doi: 10.1007/s10096-011-1391-y.
    1. Lew K.Y., Ng T.M., Tan M., Tan S.H., Lew E.L., Ling L.M., Ang B., Lye D., Teng C.B. Safety and clinical outcomes of carbapenem de-escalation as part of an antimicrobial stewardship programme in an esbl-endemic setting. J. Antimicrob. Chemother. 2015;70:1219–1225. doi: 10.1093/jac/dku479.
    1. Yeo C.L., Wu J.E., Chung G.W., Chan D.S., Chen H.H., Hsu L.Y. Antimicrobial stewardship auditing of patients reviewed by infectious diseases physicians in a tertiary university hospital. Antimicrob. Resist. Infect. Control. 2013 doi: 10.1186/2047-2994-2-29.
    1. Seah X.F., Ong Y.L., Tan S.W., Krishnaswamy G., Chong C.Y., Tan N.W., Thoon K.C. Impact of an antimicrobial stewardship program on the use of carbapenems in a tertiary women's and children's hospital, Singapore. Pharmacotherapy. 2014;34:1141–1150. doi: 10.1002/phar.1490.
    1. Chow A.L., Lye D.C., Arah O.A. Patient and physician predictors of patient receipt of therapies recommended by a computerized decision support system when initially prescribed broad-spectrum antibiotics: A cohort study. J. Am. Med. Inform. Assoc. 2015 doi: 10.1093/jamia/ocv120.
    1. Teng C.B., Ng T.M., Tan M.W., Tan S.H., Tay M., Lim S.F., Ling L.M., Ang B.S., Lye D.C. Safety and effectiveness of improving carbapenem use via prospective review and feedback in a multidisciplinary antimicrobial stewardship programme. Ann. Acad. Med. Singap. 2015;44:19–25.
    1. Liew Y.X., Lee W., Loh J.C., Cai Y., Tang S.S., Lim C.L., Teo J., Ong R.W., Kwa A.L., Chlebicki M.P. Impact of an antimicrobial stewardship programme on patient safety in Singapore general hospital. Int. J. Antimicrob. Agents. 2012;40:55–60. doi: 10.1016/j.ijantimicag.2012.03.004.
    1. Liew Y.X., Lee W., Tay D., Tang S.S., Chua N.G., Zhou Y., Kwa A.L., Chlebicki M.P. Prospective audit and feedback in antimicrobial stewardship: Is there value in early reviewing within 48 h of antibiotic prescription? Int. J. Antimicrob. Agents. 2015;45:168–173. doi: 10.1016/j.ijantimicag.2014.10.018.
    1. Yeo C.L., Chan D.S., Earnest A., Wu T.S., Yeoh S.F., Lim R., Jureen R., Fisher D., Hsu L.Y. Prospective audit and feedback on antibiotic prescription in an adult hematology-oncology unit in Singapore. Eur. J. Clin. Microbiol. Infect. Dis. 2012;31:583–590. doi: 10.1007/s10096-011-1351-6.
    1. Cai Y., Lee W., Kwa A.L. Polymyxin b versus colistin: An update. Expert Rev. Anti Infect. Ther. 2015;13:1481–1497. doi: 10.1586/14787210.2015.1093933.
    1. Li J., Rayner C.R., Nation R.L., Owen R.J., Spelman D., Tan K.E., Liolios L. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 2006;50:2946–2950. doi: 10.1128/AAC.00103-06.
    1. Zavascki A.P., Bulitta J.B., Landersdorfer C.B. Combination therapy for carbapenem-resistant gram-negative bacteria. Expert Rev. Anti Infect. Ther. 2013;11:1333–1353. doi: 10.1586/14787210.2013.845523.
    1. Morrill H.J., Pogue J.M., Kaye K.S., LaPlante K.L. Treatment options for carbapenem-resistant Enterobacteriaceae infections. Open Forum Infect. Dis. 2015 doi: 10.1093/ofid/ofv050.
    1. Falagas M.E., Lourida P., Poulikakos P., Rafailidis P.I., Tansarli G.S. Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: Systematic evaluation of the available evidence. Antimicrob. Agents Chemother. 2014;58:654–663. doi: 10.1128/AAC.01222-13.
    1. Durante-Mangoni E., Signoriello G., Andini R., Mattei A., de Cristoforo M., Murino P., Bassetti M., Malacarne P., Petrosillo N., Galdieri N., et al. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: A multicenter, randomized clinical trial. Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am. 2013;57:349–358. doi: 10.1093/cid/cit253.
    1. Lim T.P., Tan T.Y., Lee W., Sasikala S., Tan T.T., Hsu L.Y., Kwa A.L. In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore. J. Antibiot. (Tokyo) 2009;62:675–679. doi: 10.1038/ja.2009.99.
    1. Lim T.P., Lee W., Tan T.Y., Sasikala S., Teo J., Hsu L.Y., Tan T.T., Syahidah N., Kwa A.L. Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin b. PLoS ONE. 2011;6:13. doi: 10.1371/journal.pone.0028177.
    1. Lim T.P., Tan T.Y., Lee W., Sasikala S., Tan T.T., Hsu L.Y., Kwa A.L. In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore. PLoS ONE. 2011;6:13. doi: 10.1371/journal.pone.0018485.
    1. Teo J., Lim T.P., Hsu L.Y., Tan T.Y., Sasikala S., Hon P.Y., Kwa A.L., Apisarnthanarak A. Extensively drug-resistant Acinetobacter baumannii in a thai hospital: A molecular epidemiologic analysis and identification of bactericidal polymyxin B-based combinations. Antimicrob. Resist. Infect. Control. 2015 doi: 10.1186/s13756-015-0043-x.
    1. Chua N.G., Lim T.P., Lee W., Liew Y., Teo J., Cai Y., Tan T.T., Kurup A., Kwa A.L. Combination bactericidal testing-guided therapy (MCBT-GT) is effective in the treatment of extensively drug-resistant (XDR) Gram-negative bacteria (GNB) infections; Proceedings of the Interscience Conference of Antimicrobial Agents and Chemotherapy; Washington, DC, USA. 5–9 September 2014.
    1. Lim T.P., Cai Y., Hong Y., Chan E.C., Suranthran S., Teo J.Q., Lee W.H., Tan T.Y., Hsu L.Y., Koh T.H., et al. In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2015;59:2515–2524. doi: 10.1128/AAC.03639-14.
    1. Cai Y., Teo J., Lim T.P., Leck H., Lee S., Chia S., Lee W., Tan T.T., Koh T.H., Kwa A.L. Correlating molecular mechanisms of resistance of extensively-drug resistant gram negative bacteria with in vitro activity of combination antibiotics & patient outcomes; Proceedings of the Interscience Conference of Antimicrobial Agents and Chemotherapy/International Congress of Chemotherapy and Infection; San Diego, CA, USA. 17–21 September 2015.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir